These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37063437)

  • 1. Development of depot PLGA-based
    Gomaa E; Eissa NG; Ibrahim TM; El-Bassossy HM; El-Nahas HM; Ayoub MM
    Saudi Pharm J; 2023 Apr; 31(4):499-509. PubMed ID: 37063437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
    Ahmed TA; Ibrahim HM; Samy AM; Kaseem A; Nutan MT; Hussain MD
    AAPS PharmSciTech; 2014 Jun; 15(3):772-80. PubMed ID: 24648158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Alogliptin-Loaded In Situ Gel Implants by 2
    Ibrahim TM; Ayoub MM; El-Bassossy HM; El-Nahas HM; Gomaa E
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release.
    Parent M; Nouvel C; Koerber M; Sapin A; Maincent P; Boudier A
    J Control Release; 2013 Nov; 172(1):292-304. PubMed ID: 24001947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
    Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Kaseem A; Nutan MT; Hussain MD
    J Pharm Sci; 2012 Oct; 101(10):3753-62. PubMed ID: 22753324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
    Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
    J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel injectable progesterone-loaded nanoparticles embedded in SAIB-PLGA in situ depot system for sustained drug release.
    Cao Z; Tang X; Zhang Y; Yin T; Gou J; Wang Y; He H
    Int J Pharm; 2021 Sep; 607():121021. PubMed ID: 34416333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: approaches to develop PLGA based in situ gelling system with low initial burst.
    Ahmed T
    Pak J Pharm Sci; 2015 Mar; 28(2):657-65. PubMed ID: 25730797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ forming phase-inversion implants for sustained ocular delivery of triamcinolone acetonide.
    Sheshala R; Hong GC; Yee WP; Meka VS; Thakur RRS
    Drug Deliv Transl Res; 2019 Apr; 9(2):534-542. PubMed ID: 29484530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.
    Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA
    Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method.
    Beig A; Ackermann R; Wang Y; Schutzman R; Schwendeman SP
    Int J Pharm; 2022 Aug; 624():121842. PubMed ID: 35609832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial.
    Kaku K; Haneda M; Tanaka Y; Lee G; Shiki K; Miyamoto Y; Solimando F; Lee J; Lee C; George J
    Diabetes Obes Metab; 2019 Jan; 21(1):136-145. PubMed ID: 30091172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release formulations of rhVEGF₁₆₅ produce a durable response in a murine model of peripheral angiogenesis.
    Daugherty AL; Rangell LK; Eckert R; Zavala-Solorio J; Peale F; Mrsny RJ
    Eur J Pharm Biopharm; 2011 Jun; 78(2):289-97. PubMed ID: 21426936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
    Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
    Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam.
    Christian R; Thakkar V; Patel T; Gohel M; Baldaniya L; Shah P; Pandya T; Gandhi T
    Curr Drug Deliv; 2019; 16(1):66-78. PubMed ID: 30264681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release.
    Dong N; Zhu C; Jiang J; Huang D; Li X; Quan G; Liu Y; Tan W; Pan X; Wu C
    Asian J Pharm Sci; 2020 May; 15(3):347-355. PubMed ID: 32636952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ-forming PLGA implants loaded with leuprolide acetate/β-cyclodextrin complexes: mathematical modelling and degradation.
    Rahimi M; Mobedi H; Behnamghader A
    J Microencapsul; 2016 Jun; 33(4):355-64. PubMed ID: 27530523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Drug Physicochemical Properties on In-Situ Forming Implant Polymer Degradation and Drug Release Kinetics.
    Joiner JB; Prasher A; Young IC; Kim J; Shrivastava R; Maturavongsadit P; Benhabbour SR
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.